T. Rowe Price Associates’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,188,524
| Closed | -$16.4M | – | 2597 |
|
|
2017
Q1 | $16.4M | Buy |
1,188,524
+861,291
| +263% | +$11.9M | ﹤0.01% | 1232 |
|
|
2016
Q4 | $6.21M | Buy |
327,233
+1,000
| +0.3% | +$19K | ﹤0.01% | 1391 |
|
|
2016
Q3 | $7.24M | Sell |
326,233
-1,049
| -0.3% | -$23.3K | ﹤0.01% | 1373 |
|
|
2016
Q2 | $5.98M | Buy |
327,282
+65,000
| +25% | +$1.19M | ﹤0.01% | 1371 |
|
|
2016
Q1 | $4.77M | Sell |
262,282
-4,360
| -2% | -$79.3K | ﹤0.01% | 1408 |
|
|
2015
Q4 | $4.5M | Buy |
266,642
+8,610
| +3% | +$145K | ﹤0.01% | 1430 |
|
|
2015
Q3 | $4.65M | Buy |
258,032
+38,163
| +17% | +$688K | ﹤0.01% | 1445 |
|
|
2015
Q2 | $5.69M | Sell |
219,869
-12,343
| -5% | -$319K | ﹤0.01% | 1455 |
|
|
2015
Q1 | $5.09M | Buy |
+232,212
| New | +$5.09M | ﹤0.01% | 1467 |
|